MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DIVEKAR, A. Y.
Right arrow Articles by HAKALA, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DIVEKAR, A. Y.
Right arrow Articles by HAKALA, M. T.

Molecular Pharmacology, Vol 7, 663-673, Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics

Adenosine Kinase of Sarcoma 180 Cells

N6-Substituted Adenosines as Substrates and Inhibitors

A. Y. DIVEKAR 1 and M. T. HAKALA 1

1 Department of Experimental Therapeutics, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14203

Adenosine kinase (ATP:adenosine 5'-phosphotransferase, EC 2.7.1.20) was partially purified by DEAE-cellulose column chromatography from Sarcoma 180 cells grown in vitro. This enzyme preparation, which was free of adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4) but contained adenylate kinase (ATP:AMP phosphotransferase, EC 2.7.4.3), was studied with respect to its kinetic properties and specificity for substrates and inhibitors.

At pH 7.0 and 35° the Km for adenosine was 0.5 µM and the Vmax was 63 mµmoles/mg of protein per minute. Strong substrate inhibition was observed at adenosine concentrations greater than 4 µM, 50% inhibition occurring at about 100 µM. The reaction required ATP (Km = 200 µM) and Mg++. The optimal Mg++ concentrations were 0.1 and 0.25 mM at 0.5 and 2.5 mM ATP, respectively. Concentrations of Mg++ higher than these were inhibitory, and Mn++ substituted poorly for Mg++.

Most of the N6-substituted adenosine analogues which were substrates of adenosine kinase inhibited the growth of S-180 cells in vitro. Among these were two compounds which are also known to be potent cytokinins in plant systems, namely, N6-furfuryl- and N6-(Dgr2-isopentenyl)adenosine. The 5'-monophosphate of the latter compound was not phosphorylated further by adenylate kinase. The N6-substituted adenosines which were poorly or not at all phosphorylated by adenosine kinase were also poor inhibitors of S-180 cells in vitro. Several of these were potent inhibitors of the kinase, such as N6-phenyladenosine, which had a Ki value of 0.6 µM.

Note:
ACKNOWLEDGMENT The authors wish to express their appreciation to Miss Dorris Sugg for her excellent assistance in these studies.

Submitted on July 20, 1971







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics